TMED vs. XHS
TMED (T. Rowe Price Health Care ETF) and XHS (SPDR S&P Health Care Services ETF) are both Health & Biotech Equities funds. At a correlation of -0.50, they often move in opposite directions. TMED charges 0.44%/yr vs 0.35%/yr for XHS.
Performance
TMED vs. XHS - Performance Comparison
Loading charts...
Returns By Period
TMED
- 1D
- 0.00%
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XHS
- 1D
- 0.88%
- 1M
- 8.42%
- YTD
- 15.40%
- 6M
- 14.24%
- 1Y
- 28.59%
- 3Y*
- 11.29%
- 5Y*
- 1.64%
- 10Y*
- 8.61%
TMED vs. XHS - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
TMED T. Rowe Price Health Care ETF | -7.14% |
XHS SPDR S&P Health Care Services ETF | 8.54% |
Correlation
The correlation between TMED and XHS is -0.50, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jun 4, 2026 | -0.50 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMED vs. XHS — Risk / Return Rank
TMED
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
XHS
TMED vs. XHS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and SPDR S&P Health Care Services ETF (XHS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TMED | XHS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.29 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.39 | — |
| Martin ratioReturn relative to average drawdown | — | 6.63 | — |
Loading charts...
Drawdowns
TMED vs. XHS - Drawdown Comparison
The maximum TMED drawdown since its inception was -7.14%, smaller than the maximum XHS drawdown of -39.32%. Use the drawdown chart below to compare losses from any high point for TMED and XHS.
Loading charts...
Drawdown Indicators
| TMED | XHS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -7.14% | -39.32% | +32.18% |
Max Drawdown (1Y)Largest decline over 1 year | — | -11.99% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -17.81% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -32.62% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.32% | — |
Current DrawdownCurrent decline from peak | -7.14% | 0.00% | -7.14% |
Average DrawdownAverage peak-to-trough decline | -5.00% | -10.16% | +5.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 4.32% | — |
Volatility
TMED vs. XHS - Volatility Comparison
Loading charts...
Volatility by Period
| TMED | XHS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 4.47% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 12.25% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 66.28% | 17.92% | +48.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.28% | 21.13% | +45.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 66.28% | 22.40% | +43.88% |
TMED vs. XHS - Expense Ratio Comparison
TMED has a 0.44% expense ratio, which is higher than XHS's 0.35% expense ratio.
Dividends
TMED vs. XHS - Dividend Comparison
TMED has not paid dividends to shareholders, while XHS's dividend yield for the trailing twelve months is around 0.22%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TMED T. Rowe Price Health Care ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XHS SPDR S&P Health Care Services ETF | 0.22% | 0.27% | 0.38% | 0.23% | 0.19% | 0.20% | 0.23% | 2.37% | 0.34% | 0.22% | 0.28% | 0.93% |
Frequently Asked Questions
TMED and XHS have a correlation of -0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XHS is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XHS is cheaper with a 0.35% expense ratio, compared with 0.44% for TMED.
XHS has the higher dividend yield at 0.22%, compared with 0.00% for TMED.
They also come from different issuers: T. Rowe Price and State Street. Their fees differ too: 0.44% for TMED and 0.35% for XHS.
Find the right allocation for TMED and XHS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer